Patient Records

Note:

Traditional EMR platform is available but must be enabled under settings.

Hematology EMR

Diagnosis Categories

Patient List

Patient Summary

Robert Chen

62 y/o Male

DOB: 03/14/1962

MRN: MRN-7829145

Phone: (555) 123-4567

Emergency: Linda Chen (Wife) - (555) 987-6543

Diagnosis & Disease Status

Refractory

Primary Diagnosis

Acute Myeloid Leukemia (AML)

Subtype

AML with t(8;21)(q22;q22.1); RUNX1-RUNX1T1

Date of Diagnosis

06/12/2023

Risk Status

High-risk cytogenetics

Current Treatment

Venetoclax + Azacitidine

Cycle 2 (Day 14)

Started: 09/05/2023

Response Status:

Partial Response

Next Steps:

Continue current regimen with response assessment after cycle 3

Latest Lab Values

01/20/2024

WBC2.1 x10^9/L

4.5-11.0

Hgb8.9 g/dL

13.5-17.5

PLT45 x10^9/L

150-450

Blasts12 %

Neutrophils0.8 x10^9/L

1.8-7.7

Creatinine1.1 mg/dL

0.74-1.35

View TrendsLast CBC: 3 days ago

Latest Vitals

132/78

Temp

98.2°F

O₂

97%

Comorbidities

HypertensionType 2 DiabetesCoronary Artery DiseaseHyperlipidemia

Treatment Timeline

7+3 (Cytarabine + Idarubicin)

06/18/2023 - 06/25/2023

Response: Refractory

Failed to achieve remission

Venetoclax + Azacitidine

09/05/2023 - Present

Response: Ongoing

Blast reduction from 32% to 12%

Current Medications

Medication	Dosage	Frequency	Route
Venetoclax	400 mg	Daily	PO
Azacitidine	75 mg/m²	Days 1-7 of 28-day cycle	SC
Acyclovir	800 mg	BID	PO

Recent Events

01/18/2024

Hospitalization

Neutropenic fever, treated with broad-spectrum antibiotics

01/12/2024

Blood Transfusion

2 units pRBCs for symptomatic anemia (Hgb 7.2 g/dL)

01/08/2024

Bone Marrow Biopsy

Results showed 12% blasts, hypocellular marrow